D.E. Shaw & Co
RNA

D.E. Shaw & Co’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

D.E. Shaw & Co’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-131,221
Closed -$2.46M – 4326
2014
Q4 		$2.46M Buy
131,221
+92,504
+239% +$1.31M ﹤0.01% 2112
2014
Q3 		$326K Buy
+38,717
New +$367K ﹤0.01% 3639

D.E. Shaw & Co's RNA Position: Q1 2015 in Review

D.E. Shaw & Co sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q1 2015, closing a stake of 131,221 shares — an estimated $2.46M sold.

D.E. Shaw & Co first reported a position in RNA in Q3 2014 and held it in 2 quarters. The position peaked at $2.46M in Q4 2014. 0 funds tracked by Wall St. Rank hold RNA as of Q1 2015.

  • D.E. Shaw & Co reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q1 2015 after selling out during the quarter.
  • D.E. Shaw & Co sold 131,221 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q1 2015, an estimated $2.46M.
  • D.E. Shaw & Co first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2014 and held it in 2 quarters.
  • D.E. Shaw & Co's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $2.46M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.